Picture of Rapport Therapeutics logo

RAPP — Rapport Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Rapport Therapeutics To Announce Topline Results For Rap-219 Phase 2A Trial In Focal Onset Seizures On Monday, September 8, 2025

Rapport Therapeutics Inc RAPP.O:

RAPPORT THERAPEUTICS TO ANNOUNCE TOPLINE RESULTS FOR RAP-219 PHASE 2A TRIAL IN FOCAL ONSET SEIZURES ON MONDAY, SEPTEMBER 8, 2025

Source text: ID:nGNX2lTDg1

Further company coverage: RAPP.O

Recent news on Rapport Therapeutics

See all news